Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 508

1.

A review of the current use of rituximab in autoimmune diseases.

Gürcan HM, Keskin DB, Stern JN, Nitzberg MA, Shekhani H, Ahmed AR.

Int Immunopharmacol. 2009 Jan;9(1):10-25. doi: 10.1016/j.intimp.2008.10.004. Epub 2008 Nov 8. Review.

PMID:
19000786
2.

Anti B cell therapy (rituximab) in the treatment of autoimmune diseases.

Kazkaz H, Isenberg D.

Curr Opin Pharmacol. 2004 Aug;4(4):398-402. Review.

PMID:
15251135
3.

[The role of rituximab in the treatment of ANCA-associated systemic vasculitis].

Roccatello D, Vangelista A, Pani A.

G Ital Nefrol. 2011 Sep-Oct;28(5):474-88. Review. Italian.

PMID:
22028261
4.

B cells as a therapeutic target in autoimmune diseases other than rheumatoid arthritis.

Looney RJ.

Rheumatology (Oxford). 2005 May;44 Suppl 2:ii13-ii17. Review.

5.

B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia.

Zaja F, Iacona I, Masolini P, Russo D, Sperotto A, Prosdocimo S, Patriarca F, de Vita S, Regazzi M, Baccarani M, Fanin R.

Haematologica. 2002 Feb;87(2):189-95. Erratum in: Haematologica 2002 Mar;87(3):336.

6.

B cell-targeted therapy in diseases other than rheumatoid arthritis.

Looney RJ.

J Rheumatol Suppl. 2005 Feb;73:25-8; discussion 29-30. Review.

PMID:
15693113
7.

Safety of biologic therapy in rheumatoid arthritis and other autoimmune diseases: focus on rituximab.

Fleischmann RM.

Semin Arthritis Rheum. 2009 Feb;38(4):265-80. doi: 10.1016/j.semarthrit.2008.01.001. Epub 2008 Mar 12. Review.

PMID:
18336874
8.

Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases.

Gottenberg JE, Guillevin L, Lambotte O, Combe B, Allanore Y, Cantagrel A, Larroche C, Soubrier M, Bouillet L, Dougados M, Fain O, Farge D, Kyndt X, Lortholary O, Masson C, Moura B, Remy P, Thomas T, Wendling D, Anaya JM, Sibilia J, Mariette X; Club Rheumatismes et Inflammation (CRI).

Ann Rheum Dis. 2005 Jun;64(6):913-20. Epub 2004 Nov 18.

9.

B-cell depletion for autoimmune thrombocytopenia and autoimmune hemolytic anemia in pediatric systemic lupus erythematosus.

Kumar S, Benseler SM, Kirby-Allen M, Silverman ED.

Pediatrics. 2009 Jan;123(1):e159-63. doi: 10.1542/peds.2008-2361. Epub 2008 Dec 15.

PMID:
19074962
10.

Rituximab in autoimmune hematologic diseases: not just a matter of B cells.

Stasi R.

Semin Hematol. 2010 Apr;47(2):170-9. doi: 10.1053/j.seminhematol.2010.01.010. Review.

PMID:
20350664
11.

Rituximab.

Doan T, Massarotti E.

Drugs Today (Barc). 2005 Dec;41(12):785-97. Review.

PMID:
16474854
12.

What is the role of rituximab in the treatment of rheumatoid arthritis?

Atzeni F, Doria A, Turiel M, Sarzi-Puttini P.

Autoimmun Rev. 2007 Sep;6(8):553-8. Epub 2007 Mar 7. Review. Erratum in: Autoimmun Rev. 2010 Sep;9(11):793. Maurizio, Turiel [corrected to Turiel, Maurizio].

PMID:
17854748
13.
14.

Rituximab in refractory autoimmune diseases: Brazilian experience with 29 patients (2002-2004).

Scheinberg M, Hamerschlak N, Kutner JM, Ribeiro AA, Ferreira E, Goldenberg J, Kiss MH, Chahade WH.

Clin Exp Rheumatol. 2006 Jan-Feb;24(1):65-9.

PMID:
16539821
15.

[B cells as key contributors in determining the level of immune responses -B-cell-targeted therapy in patients with autoimmune diseases].

Kondo S, Akashi T, Katsuta H, Iwakiri R, Anzai K, Nagafuchi S, Niho Y, Harada M.

Fukuoka Igaku Zasshi. 2005 Apr;96(4):86-92. Review. Japanese.

PMID:
15991605
16.

Rituximab in the treatment of autoimmune haematological disorders.

Garvey B.

Br J Haematol. 2008 Apr;141(2):149-69. doi: 10.1111/j.1365-2141.2008.07054.x. Epub 2008 Mar 3. Review.

17.

Clinical effects and safety of rituximab for treatment of refractory pediatric autoimmune diseases.

El-Hallak M, Binstadt BA, Leichtner AM, Bennett CM, Neufeld EJ, Fuhlbrigge RC, Zurakowski D, Sundel RP.

J Pediatr. 2007 Apr;150(4):376-82.

PMID:
17382113
18.

Drug insight: the mechanism of action of rituximab in autoimmune disease--the immune complex decoy hypothesis.

Taylor RP, Lindorfer MA.

Nat Clin Pract Rheumatol. 2007 Feb;3(2):86-95. Review.

PMID:
17299446
19.

Rituximab in B-cell disorders other than non-Hodgkin's lymphoma.

Bosly A, Keating MJ, Stasi R, Bradstock K.

Anticancer Drugs. 2002 Nov;13 Suppl 2:S25-33. Review.

PMID:
12710588
20.

B-cell-directed therapies for autoimmune disease.

Dörner T, Radbruch A, Burmester GR.

Nat Rev Rheumatol. 2009 Aug;5(8):433-41. doi: 10.1038/nrrheum.2009.141. Epub 2009 Jul 7. Review.

PMID:
19581902
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk